Article 11
1. The programmes for the monitoring of transmissible spongiform encephalopathies (TSEs) presented by Belgium, the Czech Republic, Denmark, Germany, Estonia, Greece, Spain, France, Ireland, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Slovenia, Slovakia, Finland, Sweden, and the United Kingdom are hereby approved for the period from 1 January 2006 to 31 December 2006. 2. The financial contribution by the Community shall be at the rate of 100 % of the costs to be incurred by each Member State referred to in paragraph 1 for the implementation of those programmes and shall not exceed: (a) EUR 3 155 000 for Belgium; (b) EUR 1 485 000 for the Czech Republic; (c) EUR 2 115 000 for Denmark; (d) EUR 13 940 000 for Germany; (e) EUR 225 000 for Estonia; (f) EUR 545 000 for Greece; (g) EUR 8 305 000 for Spain; (h) EUR 24 395 000 for France; (i) EUR 5 035 000 for Ireland; (j) EUR 7 345 000 for Italy; (k) EUR 280 000 for Cyprus; (l) EUR 340 000 for Latvia; (m) EUR 700 000 for Lithuania; (n) EUR 135 000 for Luxembourg; (o) EUR 915 000 for Hungary; (p) EUR 25 000 for Malta; (q) EUR 4 375 000 for the Netherlands; (r) EUR 1 755 000 for Austria; (s) EUR 3 430 000 for Poland; (t) EUR 1 605 000 for Portugal; (u) EUR 390 000 for Slovenia; (v) EUR 665 000 for Slovakia; (w) EUR 935 000 for Finland; (x) EUR 285 000 for Sweden; (y) EUR 5 925 000 for the United Kingdom. 3. The financial contribution by the Community of the programmes referred to in paragraph 1 shall be for the tests performed and the maximum amount shall not exceed: (a) EUR 7 per test, for tests carried out in bovine and ovine animals referred to in Annex III to Regulation (EC) No 999/2001; (b) EUR 30 per test, for tests carried out in caprine animals referred to in Annex III to Regulation (EC) No 999/2001; (c) EUR 145 per test, for primary molecular discriminatory tests carried out as referred to in Annex X, Chapter C, point 3.2(c)(i) to Regulation (EC) No 999/2001.